In an industry where emotional stakes are impossibly high and margins for error are razor-thin, AIVF isn't just building software—they are building a statistical safety net for the future of human creation. By applying heavy AI to embryology, they are attempting to turn the art of IVF into a precise science.

"AIVF isn't just digitizing records; they are digitizing the decision-making process of selecting the single most viable embryo."

The tech stack reveals a pragmatic approach: WordPress for content management, jQuery and Slick for UI, and CookieYes for compliance. While not bleeding-edge, this stack prioritizes stability and speed of deployment—critical for a Series A/B stage company scaling in a regulated environment. The lack of public funding data alongside $25M+ revenue suggests a potentially self-sustaining or late-stage bootstrapped model, a rarity in the capital-intensive femtech space.

• Revenue Focus: $25.1M annual revenue indicates strong product-market fit and paid adoption.
• Niche SEO Dominance: Capturing high-volume, specific fertility queries rather than generic terms.
• Lean Operations: 93 employees managing a complex AI healthcare product suggests high automation.
• Brand Recall: 44% direct traffic implies strong word-of-mouth and clinical referral networks.